It is true that autologous stem cell transplantation can be used to treat dermatomyositis, but currently the main treatment for dermatomyositis is medication.
Dermatomyositis is an autoimmune connective tissue disease with muscle and skin lesions, and common symptoms of patients include papules, skin erythema, muscle weakness, etc. At present, the main treatment of dermatomyositis is drug therapy, but dermatomyositis is also in line with the indications of autologous stem cell transplantation treatment.
According to the relevant treatment guidelines, autologous stem cell transplantation can be used to treat autoimmune diseases such as adult dermatomyositis, systemic lupus erythematosus, multiple sclerosis, etc. However, the specific treatment plan for patients with dermatomyositis needs to be individualized according to the differences in patients’ individual factors and specific conditions.
It is recommended that patients with dermatomyositis go to the rheumatology and immunology department of a regular hospital to have a professional doctor choose an appropriate treatment plan.